Next Article in Journal
Codon Pattern and Compositional Constraints Determination of Genes Associated with Chronic Periodontitis
Previous Article in Journal
The Impact of TSC-1 and -2 Mutations on Response to Therapy in Malignant PEComa: A Multicenter Retrospective Analysis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Genes
Volume 13
Issue 11
10.3390/genes13111933
genes-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Circulating mtDNA and Impaired Intestinal Barrier after Gastrointestinal Surgery Are Correlated with Postoperative SIRS

by
Can Kong
1,†,
Wei Song
1,†,
Jun Ren
1,
Dingshan Zhou
2,
Jiazheng Li
1,
Renshen Xiang
1 and
Tao Fu
1,3,*
1
Department of Gastrointestinal Surgery II, Renmin Hospital of Wuhan University, Wuhan 430060, China
2
Intravenous Drug Dispensing Center, Renmin Hospital of Wuhan University, Wuhan 430060, China
3
Department of General Surgery, Qingdao Municipal Hospital, Qingdao 266071, China
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Genes 2022, 13(11), 1933; https://doi.org/10.3390/genes13111933
Submission received: 9 August 2022 / Revised: 29 September 2022 / Accepted: 21 October 2022 / Published: 24 October 2022
(This article belongs to the Section Molecular Genetics and Genomics)
Browse Figures
Versions Notes

Abstract

:
Background: This prospective study aimed to explore the correlation between circulating mitochondrial DNA (mtDNA), intestinal barrier function impairment, and postoperative SIRS in patients undergoing gastrointestinal surgery. Methods: Patients were recruited into this study after signing an informed consent form. Circulating mitochondrial DNA and serum DAO concentrations were measured preoperatively and on day 1 and day 7 postoperatively. Postoperative vitals, routine tests, and biochemical indicators were recorded in detail. Results: Forty patients undergoing gastrointestinal surgery were recruited for and completed this study. Patients were divided into non-fever, fever, and SIRS groups according to their postoperative temperature and other corresponding indexes. The mtDNA was expressed as the number of PCR cycles using three specific sequences. Circulating mtDNA tended to increase in patients after gastrointestinal surgery, but the difference was not significant. Nevertheless, mtDNA in the SIRS group was significantly higher than in patients in the fever and non-fever groups (p < 0.05). Serum DAO showed a trend of increase on the first day after surgery compared with that before surgery, but the difference was not significant (p > 0.05). However, patients in the SIRS group showed a significant increase (p < 0.05) compared with the others. Both circulating mtDNA and DAO showed a downward trend on the seventh day after surgery. Conclusions: Circulating mtDNA presented a trend of increase after gastrointestinal surgery, and the degree of the increased fold was related to the extent of the inflammation response. In general, the intestinal barrier damage indicator DAO was the same as mtDNA and tended to increase after gastrointestinal surgery and then gradually decrease, which may play a synergistic role in inducing postoperative fever and SIRS.

1. Introduction

Mitochondria are the key organelles of cellular energy metabolism. At the same time, mitochondria determine cells’ physiological function and serve a vital role in the immune response [1]. Important damage-associated molecular patterns (DAMPs), such as mitochondrial DNA released after mitochondrial damage caused by severe trauma or abdominal surgery, may impact the respiratory chain, enhance oxidative stress, and activate systemic inflammatory responses through diverse inflammatory signaling pathways [2,3,4]. Severe cases may even lead to SIRS (systemic inflammatory response syndrome), MODS (multiple organ dysfunction syndrome), and death [5]. By testing the postoperative circulating mtDNA levels in patients following pancreaticoduodenectomy, Pencovich et al. [6] found that circulating mtDNA surge is correlated with patients’ postoperative inflammatory response, suggesting that abdominal surgery may contribute to patients’ postoperative inflammatory response by releasing mtDNA. One of our recent reviews also detailed the pathophysiological mechanisms of the inflammatory response induced by mitochondrial damage [7].
Intestinal homeostasis involves the interaction between the intestinal flora, the protective mucus layer, and various intestinal cells (intestinal epithelial cells, myeloid cells, and lymphocytes) [8,9]. The crucial role of intestinal homeostasis is particularly important due to the large direct contact of the intestinal lumen with the “external” environment. When this balance is disrupted, the possibility of endogenous danger signals increases. Those signals are generated by microorganisms and their metabolites, as well as abiotic, xenobiotic, and self-interactions in the intestinal lumen [10].
It has already been found in animal experiments and clinical studies that even minor intestinal manipulation can cause increased permeability of the intestinal mucosa. Similar phenomena have been observed in open cholecystectomy, laparoscopic cholecystectomy, and even in cardiac surgery, chronic liver cirrhosis, severe trauma, and other critical illness [11,12,13,14,15,16]. As a result of increased permeability, intestinal bacteria, endotoxins, and other harmful substances migrate into the bloodstream and trigger a series of pathophysiological processes, including SIRS and MODS.
Diamine oxidase (DAO) is only synthesized in the epithelial cells of the intestinal villi. It breaks down polyamines such as histamine and controls the proliferation of the mucosa [17]. The release of DAO from damaged mucosal cells increases their serum concentration [18]. Therefore, this indicator has a certain value in assessing the degree of intestinal barrier damage. Both our research and other, previous studies have confirmed the value of DAO in assessing intestinal barrier function impairment after gastrointestinal surgery [19,20,21].
In this study, we aim to assess the relationship between mtDNA, impaired intestinal barrier, and SIRS in patients undergoing gastrointestinal surgery so as to explore its clinical application to forewarn SIRS and intestinal barrier dysfunction after gastrointestinal surgery.

2. Patients and Methods

2.1. Ethics Statement

Patients undergoing gastrointestinal surgery were recruited for this study, and this study protocol was approved; all patients signed an informed consent form prior to performing any study-related procedures.
The inclusion criteria were: patients were diagnosed with colorectal cancer, gastric cancer, or gastrointestinal disorders (gastrointestinal mesenchymal tumor, strangulated intestinal obstruction, intestinal torsion, Crohn’s disease, etc.) needing surgical treatment; age from 18 to 90 years; hepatic function Child-Pugh classification of grade A or B; and clear consciousness and ability to communicate with researchers in normal language.
The exclusion criteria were: patients who were not undergoing surgical treatment; significant abnormalities in preoperative biochemical tests: dyslipidemia (total triglycerides > 2.26 mmol/L or total cholesterol > 6.2 mmol/L) or renal impairment (creatinine > 122 µmol/L or urea > 10.7 mmol/L); those who had recently received radiotherapy; those who had recently received hormone therapy; presence of preoperative fever (temperature over 37.2); patients on anti-pyretic therapy (e.g., paracetamol, Tylenol, aspirin, etc.); and co-morbidities such as diabetes, autoimmune diseases, and inflammatory diseases.
The primary outcome was postoperative fever; secondary outcomes involved SIRS, MODS, and death. SIRS was defined according to the American College of Chest Physicians/Society of Critical Care Medicine [22]. MODS was defined according to the Denver Postinjury Multiple Organ Failure criteria with a score of 4 or higher [23].

2.2. Blood Sampling

Blood samples were collected on admission to the hospital, day 1 after surgery, and day 7 after surgery. These blood samples were collected into ethylenediaminetetraacetic acid (EDTA)-containing tubes and centrifuged twice at 3000 revolutions per minute (rpm), and 10,000 rpm, both for 10 min. The upper part of the plasma was transferred into another clear tube and stored at −80 °C before DNA extraction or enzyme linked immunosorbent assay (ELISA).

2.3. Measurement of mtDNA in Plasma

DNA was isolated from plasma using the QIAamp DNA Blood Midi Kit (Qiagen, Valencia, CA) according to the manufacturer’s protocol. Quantitative real-time polymerase chain reaction (qPCR) was then performed using Universal Blue qPCR SYBR Green Master Mix (Yeasen Biotechnology, Shanghai Co., Ltd. CN). The primers for qPCR analysis of mtDNA sequences were Human cytochrome B F: ATG ACC CCA ATA CGC AAA AT R: CGA AGT TTC ATC ATG CGG AG; MT-ND2 F: CAC AGA AGC TGC CAT CAA GTA R: CCG GAG AGT ATA TTG TTG AAG AG; COX1 F: TCA TCT GTA GGC TCA TTC R: GCG ATC CAT ATA GTC ACT. These mitochondrial genomic regions for primers of qPCR were described previously [4,24]. The total volume of the reaction system was 20 uL, and the relative plasma mtDNA abundance was denoted as the threshold cycle (Tc).

2.4. Assessment of Plasma DAO

Human serum DAO concentration was measured using the ELISA Kit provided by Cusabio Biotech Co., Ltd. (Wuhan, China). We detected mtDNA and DAO in preoperative plasma as negative controls.

2.5. Statistical Analysis

Statistical analyses were performed using the SPSS 25.0 statistical software (SPSS Inc. Chicago, IL, USA). Figures and tables were performed by the GraphPad Prism 8.0 (GraphPad Software, Inc., San Diego, CA, USA) and Word 2016 software (Microsoft, Redmond, WA, USA), respectively. Analysis of variance (ANOVA) by Tukey’s test was used to analyze differences between groups. The data were expressed as mean ± SD. A p-value < 0.05 was considered statistically significant.

3. Results

During the study period, 40 consecutive patients were enrolled. Patients were divided into non-fever, fever, and SIRS groups according to their postoperative temperature and other corresponding indexes (heart rate > 90/min; respiratory rate > 20/min or PaCO2 < 32 mmHg; white blood cell count >12 × 109/L, <4 × 109/L, or >10% immature (band) forms). The characteristics of the patients are indicated in Table 1. There were no serious complications and no deaths, except for one patient who had bleeding on the wound around the anastomosis after surgery and underwent a second operation. The average ages of the groups were 57 ± 15.18, 62.52 ± 6.64, and 72.17 ± 4.79, respectively. There was no statistically significant difference between the non-fever group and the fever group, but there were significant differences between the non-fever and SIRS groups, as well as between the fever group and the SIRS group (p < 0.05).

3.1. mtDNA Levels

The concentration of mtDNA in plasma is quantified as PCR Tc, and the amount of DNA doubles with each cycle until the detection threshold is reached. mtDNA in peripheral blood was measured before the operation, on the first day, and on the seventh day after the operation. Template DNA was considered to have a Tc value of 40 as the limit of detection. Therefore, all serum samples had Tc values below 40. The test results showed an upward trend in mtDNA levels on the first postoperative day in contrast to the preoperative day, and a downward trend on the seventh postoperative day compared to the first postoperative day, but none of these differences were significant (p > 0.05) (Figure 1).

3.2. mtDNA Levels in Three Groups

Patients were divided into three groups according to whether they had a fever or met the diagnostic criteria of SIRS after surgery, namely, the non-fever group (n = 9), fever group (n = 25), and SIRS group (n = 6). Statistical analysis showed that the mtDNA level in the SIRS group was significantly higher than in the no fever and fever group (p < 0.05) in three kinds of primers (Table 2).

3.3. DAO Concentration

Similar to the trend of mtDNA, DAO concentration also increased significantly on the first postoperative day compared with before surgery—64.65 ± 31.22 mIU/mL vs. 85.03 ± 39.61 mIU/mL (p < 0.05)—and it gradually decreased to near preoperative levels on the seventh postoperative day, reaching 76.54 ± 40.73 mIU/mL (Figure 2).

3.4. DAO Concentration in Three Groups

Analysis of DAO level differences among the three groups showed that there were significant differences between the non-fever group and the SIRS group and between the fever group and the SIRS group (p < 0.05), while there was no significant difference between the non-fever group and the fever group (p > 0.05) (Figure 3).

3.5. Correlations between mtDNA and DAO

Correlation analysis between mtDNA detected by three primers and DAO showed that there was no significant correlation between mtDNA and DAO concentration before operation; human cytochrome B and MT-ND2 were significantly correlated with DAO concentration after operation. However, the correlation coefficient was minimal (Table 3). This indicates that postoperative mtDNA release and impaired intestinal barrier could be independent but synergistic factors in inducing postoperative fever or SIRS.
In addition, we found that the concentration of albumin and prealbumin in patients decreased significantly on the first postoperative day compared with pre-operation, and we observed gradual regression to near preoperative levels by postoperative day 7 (Figure 4). While levels of postoperative albumin, which reflect short-term nutritional status, were lowest in the SIRS group, they were not significantly different from the other two groups (p > 0.05), suggesting that nutritional status may be related to the inflammatory response of surgical patients, but further verification is needed.

4. Discussion

Previous studies have shown that fever and inflammation after trauma or surgery are frequent and greatly influence patient clinical outcomes [5,25]; development of inflammation is associated with poor prognosis, e.g., increased use of intensive care, longer hospital stays, and increased mortality. Nevertheless, inflammation remains a neglected and underreported pathophysiological change in patients with severe trauma or surgery, especially in older patients [24,26]. mtDNA, as an important damage-associated molecular pattern (DAMP), could enhance oxidative stress and initiate systemic inflammatory responses. In some severe cases, mtDNA can lead to sepsis, MODS, and even death [6,27,28].
The intestinal epithelium is a multicellular interface close to a complex microbial environment and completes renewal every 3–5 days [29]. The intestinal epithelium is richly and specifically supplied by a vascular system, but this high metabolism and the specific villi microvascular structure make the intestinal mucosa particularly sensitive to microenvironmental disturbances [30]. During inflammation, alterations in blood flow, vascular integrity, and capillary pathological permeability predispose to impaired tissue oxygenation. Thus, various causes of inadequate intestinal perfusion can lead to increased intestinal permeability and impaired intestinal mucosal barrier function [31,32].
In this study, we found that after gastrointestinal surgery, patients in the SIRS group had significantly higher levels of mtDNA and DAO than before surgery. mtDNA and DAO in patients with SIRS were significantly higher than before surgery, and patients with postoperative fever but not yet meeting the diagnostic criteria of SIRS also showed an increasing trend, suggesting that mtDNA may play an active role in the progression of postoperative fever and SIRS. The increase of DAO after surgery may reflect the impairment of intestinal barrier function, which may lead to the displacement of intestinal flora and induce SIRS or even MODS together with mtDNA. In addition, it was found that mtDNA and DAO had the same upward and downward trends. However, there was no significant correlation between them, suggesting that postoperative mtDNA release and impaired intestinal barrier might be independent but synergistic factors in inducing postoperative fever or SIRS. Nonetheless, this hypothesis merits further study. In addition, we found that the occurrence of postoperative fever and SIRS was positively correlated with patient age, i.e., the older the patients are, the more likely they are to develop postoperative fever and SIRS, further demonstrating that older patients are less tolerant of surgical trauma than younger patients.
Some studies have found increased inflammatory responses in patients with disease-related malnutrition [33], and our study observed a similar phenomenon. That is, both albumin and prealbumin showed a decreasing trend after surgery. The decreased degree of prealbumin in the SIRS group seems higher than that in the non-fever group and fever group, but the difference is not significant (p > 0.05), and further research is needed (Figure 4). Therefore, timely and effective nutritional support should be implemented for patients at risk of malnutrition after major gastrointestinal surgery.

5. Conclusions

Postoperative fever and SIRS are associated with advanced age as well as hypoproteinemia. Circulating mtDNA tended to increase after gastrointestinal surgery, and the fold of the increase was related to the degree of inflammation response. DAO, an indicator of intestinal barrier damage, was the same as mtDNA, with a general trend of increase after gastrointestinal surgery and then a gradual decrease, which may play a synergistic role in inducing postoperative fever and SIRS. However, as this study is a small single-center study, its clinical application value needs further validation.

Author Contributions

(I) Conception and design: T.F., C.K. and J.R.; (II) collection and assembly of data: C.K., D.Z., W.S. and J.L.; (III) data analysis and interpretation: C.K. and R.X.; (IV) manuscript writing: all authors; (V) final approval of manuscript: all authors. All authors have read and agreed to the published version of the manuscript.

Funding

The present study was supported by the Clinical Research Fund project of the Zhejiang Medical Association (grant no. 2019ZYC-A182), and The Talent Introduction Fund of Wuhan University Renmin Hospital (grant no. NA to T.F.).

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Renmin Hospital of Wuhan University, protocol code WDRY2022-K085 and date of approval 30 June 2022.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author T.F., upon reasonable request.

Conflicts of Interest

The authors declare that they have no competing interests.

References

  1. Ca, P. Mitochondrial DNA, oxidants, and innate immunity. Free Radic. Biol. Med. 2020, 52, 455–461. [Google Scholar] [CrossRef]
  2. Zhang, X.; Wu, J.; Liu, Q.; Li, X.; Li, S.; Chen, J.; Hong, Z.; Wu, X.; Zhao, Y.; Ren, J. mtDNA-STING pathway promotes necroptosis-dependent enterocyte injury in intestinal ischemia reperfusion. Cell Death Dis. 2020, 11, 1050. [Google Scholar] [CrossRef] [PubMed]
  3. Vringer, E.; Tait, S.W.G. Mitochondria and Inflammation: Cell Death Heats Up. Front. Cell Dev. Biol. 2019, 7, 100. [Google Scholar] [CrossRef] [PubMed]
  4. Simmons, J.D.; Lee, Y.; Mulekar, S.; Kuck, J.L.; Brevard, S.B.; Gonzalez, R.P.; Gillespie, M.N.; Richards, W.O. Elevated Levels of Plasma Mitochondrial DNA DAMPs Are Linked to Clinical Outcome in Severely Injured Human Subjects. Ann. Surg. 2013, 258, 591–598. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Schneck, E.; Edinger, F.; Hecker, M.; Sommer, N.; Pak, O.; Weissmann, N.; Hecker, A.; Reichert, M.; Markmann, M.; Sander, M.; et al. Blood Levels of Free-Circulating Mitochondrial DNA in Septic Shock and Postsurgical Systemic Inflammation and Its Influence on Coagulation: A Secondary Analysis of a Prospective Observational Study. J. Clin. Med. 2020, 9, 2056. [Google Scholar] [CrossRef]
  6. Pencovich, N.; Nevo, N.; Weiser, R.; Bonder, E.; Bogoch, Y.; Nachmany, I. Postoperative Rise of Circulating Mitochondrial DNA Is Associated with Inflammatory Response in Patients following Pancreaticoduodenectomy. Eur. Surg. Res. 2021, 62, 18–24. [Google Scholar] [CrossRef]
  7. Kong, C.; Song, W.; Fu, T. Systemic inflammatory response syndrome is triggered by mitochondrial damage (Review). Mol. Med. Rep. 2022, 25, 147. [Google Scholar] [CrossRef]
  8. Vita, A.A.; Royse, E.A.; Pullen, N.A. Nanoparticles and danger signals: Oral delivery vehicles as potential disruptors of intestinal barrier homeostasis. J. Leukoc. Biol. 2019, 106, 95–103. [Google Scholar] [CrossRef]
  9. Farhadi, A.; Banan, A.; Fields, J.; Keshavarzian, A. Intestinal barrier: An interface between health and disease. J Gastroenterol. Hepatol. 2003, 18, 479–497. [Google Scholar] [CrossRef]
  10. Chelakkot, C.; Ghim, J.; Ryu, S.H. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp. Mol. Med. 2018, 50, 1–9. [Google Scholar] [CrossRef]
  11. Pan, P.; Song, Y.; Du, X.; Bai, L.; Hua, X.; Xiao, Y.; Yu, X. Intestinal barrier dysfunction following traumatic brain injury. Neurol. Sci. 2019, 40, 1105–1110. [Google Scholar] [CrossRef] [PubMed]
  12. He, W.; Wang, Y.; Wang, P.; Wang, F. Intestinal barrier dysfunction in severe burn injury. Burn. Trauma 2019, 7, 24. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Schietroma, M.; Carlei, F.; Cappelli, S.; Amicucci, G. Intestinal Permeability and Systemic Endotoxemia After Laparotomic or Laparoscopic Cholecystectomy. Ann. Surg. 2006, 243, 359–363. [Google Scholar] [CrossRef]
  14. Derikx, J.P.M.; van Waardenburg, D.A.; Thuijls, G.; Willigers, H.M.; Koenraads, M.; van Bijnen, A.A.; Heineman, E.; Poeze, M.; Ambergen, T.; van Ooij, A.; et al. New Insight in Loss of Gut Barrier during Major Non-Abdominal Surgery. PLoS ONE 2008, 3, e3954. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Xia, X.; Ni, J.; Yin, S.; Yang, Z.; Jiang, H.; Wang, C.; Peng, J.; Wei, H.; Wang, X. Elevated Systemic and Intestinal Inflammatory Response Are Associated With Gut Microbiome Disorder After Cardiovascular Surgery. Front. Microbiol. 2021, 12, 686648. [Google Scholar] [CrossRef] [PubMed]
  16. Voulgaris, T.A.; Karagiannakis, D.; Hadziyannis, E.; Manolakopoulos, S.; Karamanolis, G.P.; Papatheodoridis, G.; Vlachogiannakos, J. Serum zonulin levels in patients with liver cirrhosis: Prognostic implications. World J. Hepatol. 2021, 13, 1394–1404. [Google Scholar] [CrossRef]
  17. Manzotti, G.; Breda, D.; Di Gioacchino, M.; Burastero, S.E. Serum diamine oxidase activity in patients with histamine intolerance. Int. J. Immunopathol. Pharm. 2016, 29, 105–111. [Google Scholar] [CrossRef] [Green Version]
  18. Cai, J.; Chen, H.; Weng, M.; Jiang, S.; Gao, J. Diagnostic and Clinical Significance of Serum Levels of D-Lactate and Diamine Oxidase in Patients with Crohn’s Disease. Gastroent. Res. Pract. 2019, 2019, 8536952. [Google Scholar] [CrossRef]
  19. Kong, C.; Li, S.; Yang, H.; Xiao, W.; Cen, Y.; Wu, Y.; Li, W.; Sun, D.; Xu, P. Screening and combining serum biomarkers to improve their diagnostic performance in the detection of intestinal barrier dysfunction in patients after major abdominal surgery. Ann. Transl. Med. 2019, 7, 388. [Google Scholar] [CrossRef]
  20. Chunchun Yang, X.Z.S.W. Small intestinal bacterial overgrowth and evaluation of intestinal barrier function in patients with ulcerative colitis. Am. J. Transl. Res. 2021, 13, 6605–6610. [Google Scholar]
  21. Zhang, L.; Fan, X.; Zhong, Z.; Xu, G. Association of Plasma DAO and iFABP with Severity of Disease In Patient with Heat Stroke. Am. J. Emerg. Med. 2015, 33, 867–871. [Google Scholar] [CrossRef] [PubMed]
  22. Bone, R.C.; Balk, R.A.; Cerra, F.B.; Dellinger, R.P.; Fein, A.M.; Knaus, W.A.; Schein, R.M.; Sibbald, W.J. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101, 1644–1655. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Sauaia, A.; Moore, E.E.; Johnson, J.L.; Ciesla, D.J.; Biffl, W.L.; Banerjee, A. Validation of postinjury multiple organ failure scores. Shock 2009, 31, 438–447. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Hu, Q.; Ren, J.; Wu, J.; Li, G.; Wu, X.; Liu, S.; Wang, G.; Gu, G.; Li, J. Elevated Levels of Plasma Mitochondrial DNA Are Associated with Clinical Outcome in Intra-Abdominal Infections Caused by Severe Trauma. Surg. Infect. 2017, 18, 610–618. [Google Scholar] [CrossRef]
  25. Cheadle, W.G.; Mercer-Jones, M.; Heinzelmann, M.; Polk, H.J. Sepsis and septic complications in the surgical patient: Who is at risk? Shock 1996, 6 (Suppl. S1), S6–S9. [Google Scholar] [CrossRef]
  26. Freundlich, R.E.; Maile, M.D.; Sferra, J.J.; Jewell, E.S.; Kheterpal, S.; Engoren, M. Complications Associated With Mortality in the National Surgical Quality Improvement Program Database. Anesth. Analg. 2018, 127, 55–62. [Google Scholar] [CrossRef]
  27. Itagaki, K.; Riça, I.; Konecna, B.; Kim, H.I.; Park, J.; Kaczmarek, E.; Hauser, C.J. Role of Mitochondria-Derived Danger Signals Released After Injury in Systemic Inflammation and Sepsis. Antioxid. Redox Sign. 2021, 35, 1273–1290. [Google Scholar] [CrossRef]
  28. Wu, Z.; Sainz, A.G.; Shadel, G.S. Mitochondrial DNA: Cellular genotoxic stress sentinel. Trends Biochem. Sci. 2021, 46, 812–821. [Google Scholar] [CrossRef]
  29. Barker, N. Adult intestinal stem cells: Critical drivers of epithelial homeostasis and regeneration. Nat. Rev. Mol. Cell Bio. 2014, 15, 19–33. [Google Scholar] [CrossRef] [Green Version]
  30. Colgan, S.P.; Taylor, C.T. Hypoxia: An alarm signal during intestinal inflammation. Nat. Rev. Gastroenterol. Hepatol. 2010, 7, 281–287. [Google Scholar] [CrossRef] [Green Version]
  31. Otani, S.; Coopersmith, C.M. Gut integrity in critical illness. J. Intensive Care 2019, 7, 17. [Google Scholar] [CrossRef] [PubMed]
  32. Klingensmith, N.J.; Coopersmith, C.M. The Gut as the Motor of Multiple Organ Dysfunction in Critical Illness. Crit. Care Clin. 2016, 32, 203–212. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Bañuls, C.; de Marañón, A.M.; Castro-Vega, I.; López-Doménech, S.; Escribano-López, I.; Salom, C.; Veses, S.; Hernández-Mijares, A. Role of Endoplasmic Reticulum and Oxidative Stress Parameters in the Pathophysiology of Disease-Related Malnutrition in Leukocytes of an Outpatient Population. Nutrients 2019, 11, 1838. [Google Scholar] [CrossRef] [PubMed]
Genes 13 01933 g001 550
Figure 1. The results of mtDNA-PCR indicated that the Tc value on the first day after surgery was lower than that before surgery, and it showed an upward trend on the seventh day but was still lower than that before surgery. However, statistical analysis showed no significant difference (p > 0.05). Note: the lower the Tc value, the higher the mtDNA concentration.
Figure 1. The results of mtDNA-PCR indicated that the Tc value on the first day after surgery was lower than that before surgery, and it showed an upward trend on the seventh day but was still lower than that before surgery. However, statistical analysis showed no significant difference (p > 0.05). Note: the lower the Tc value, the higher the mtDNA concentration.
Genes 13 01933 g001
Genes 13 01933 g002 550
Figure 2. DAO concentration. Similar to the trend of mtDNA, DAO concentration also increased significantly on the first postoperative day compared with before surgery—64.65 ± 31.22 mIU/mL vs. 85.03 ± 39.61 mIU/mL (p < 0.05)—and gradually decreased to the preoperative level on the seventh day, reaching 76.54 ± 40.73 mIU/mL. * means p < 0.05.
Figure 2. DAO concentration. Similar to the trend of mtDNA, DAO concentration also increased significantly on the first postoperative day compared with before surgery—64.65 ± 31.22 mIU/mL vs. 85.03 ± 39.61 mIU/mL (p < 0.05)—and gradually decreased to the preoperative level on the seventh day, reaching 76.54 ± 40.73 mIU/mL. * means p < 0.05.
Genes 13 01933 g002
Genes 13 01933 g003 550
Figure 3. Association of DAO levels with fever or SIRS serum DAO level was detected, segregating patients based on the occurrence of fever and SIRS, with statistical difference between Non-fever and SIRS and between Fever and SIRS, but no statistical difference between Non-fever and Fever. ** means p < 0.01. *** means p < 0.001.
Figure 3. Association of DAO levels with fever or SIRS serum DAO level was detected, segregating patients based on the occurrence of fever and SIRS, with statistical difference between Non-fever and SIRS and between Fever and SIRS, but no statistical difference between Non-fever and Fever. ** means p < 0.01. *** means p < 0.001.
Genes 13 01933 g003
Genes 13 01933 g004 550
Figure 4. Serum prealbumin and albumin levels were detected; they were significantly decreased on the first postoperative day and gradually recovered on the seventh postoperative day but were still lower than the preoperative level (p > 0.05). * means p < 0.05; ** means p < 0.01; *** means p < 0.001.
Figure 4. Serum prealbumin and albumin levels were detected; they were significantly decreased on the first postoperative day and gradually recovered on the seventh postoperative day but were still lower than the preoperative level (p > 0.05). * means p < 0.05; ** means p < 0.01; *** means p < 0.001.
Genes 13 01933 g004
Table
Table 1. Individual Patient Characteristics.
Table 1. Individual Patient Characteristics.
Basic InformationTotal
(n = 40)		No Fever
(n = 9)		Fever
(n = 25)		SIRS
(n = 6)		p Value
Age (years)62.73 ± 9.9357 ± 15.1862.52 ± 6.6 *72.17 ± 4.79 **0.01
Sex ratio (male:female)23/405/414/114/20.68
Types of surgery 0.77
Radical resection for gastric cancer206113
Radical resection for colon cancer10172
Radical resection for rectum cancer8170
Enterectomy and anastomosis2101
Legend: Values are expressed as mean ± SD. Statistically significant differences are shown in bold. p-values were calculated by the Mann–Whitney U test and the chi-square test. * means compared with non-fever group, p < 0.05. ** means compared with non-fever group, p < 0.01.
Table
Table 2. Association of mtDNA levels with fever or SIRS.
Table 2. Association of mtDNA levels with fever or SIRS.
mtDNA LevelsNon-FeverFeverSIRS
Human cytochrome B29.60 ± 1.9829.94 ± 1.9526.62 ± 1.35 ** ##
COX133.74 ± 0.8834.19 ± 1.7130.75 ± 1.60 ** ##
MT-ND229.39 ± 1.9229.84 ± 1.7126.99 ± 1.20 ** ##
Legend: mtDNA = mitochondrial deoxyribonucleic acid; SIRS = systemic inflammatory response syndrome. Serum mtDNA levels for three different sequences were detected, segregating patients based on the occurrence of fever and SIRS, with statistical differences in every sequence. There were no significant differences between the non-fever group and the fever group (p > 0.05). Between the non-fever group and the SIRS group, and between the fever group and the SIRS group, there was a statistical difference in every sequence (p < 0.05). Each polymerase chain reaction cycle represents a doubling of the DNA quantity. ** means compared with the non-fever group, p < 0.01. ## means compared with the fever group, p < 0.01.
Table
Table 3. Correlations between mtDNA and DAO.
Table 3. Correlations between mtDNA and DAO.
DAOPreoperativelyPostoperatively
Correlation Coefficientp ValueCorrelation Coefficientp-Value
Human cytochrome B0.0200.905−0.1590.037
COX1−0.0090.966−0.2820.075
MT-ND2−0.1080.514−0.2060.007
Legend: DAO, diamine oxidase. Plasma mtDNA level was quantified as PCR Tc; plasma DAO concentration was quantified as mIU/mL.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kong, C.; Song, W.; Ren, J.; Zhou, D.; Li, J.; Xiang, R.; Fu, T. Circulating mtDNA and Impaired Intestinal Barrier after Gastrointestinal Surgery Are Correlated with Postoperative SIRS. Genes 2022, 13, 1933. https://doi.org/10.3390/genes13111933

AMA Style

Kong C, Song W, Ren J, Zhou D, Li J, Xiang R, Fu T. Circulating mtDNA and Impaired Intestinal Barrier after Gastrointestinal Surgery Are Correlated with Postoperative SIRS. Genes. 2022; 13(11):1933. https://doi.org/10.3390/genes13111933

Chicago/Turabian Style

Kong, Can, Wei Song, Jun Ren, Dingshan Zhou, Jiazheng Li, Renshen Xiang, and Tao Fu. 2022. "Circulating mtDNA and Impaired Intestinal Barrier after Gastrointestinal Surgery Are Correlated with Postoperative SIRS" Genes 13, no. 11: 1933. https://doi.org/10.3390/genes13111933

APA Style

Kong, C., Song, W., Ren, J., Zhou, D., Li, J., Xiang, R., & Fu, T. (2022). Circulating mtDNA and Impaired Intestinal Barrier after Gastrointestinal Surgery Are Correlated with Postoperative SIRS. Genes, 13(11), 1933. https://doi.org/10.3390/genes13111933

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop